Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Mesna × Sarcoma × Clear all

Phase

Phase 2 8 Phase 1 7 Phase NA 4 Phase 3 2 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Lymphoid 8 Breast 4 Myeloid 3 Plasma cell 2 Gastrointestinal 2 Tumor-Agnostic 1 Sarcoma 1 Dermatologic 1 Classical hematology 1

Conditions

Interventions

Temozolomide 29 Radiotherapy 27 Irinotecan 14 Gemcitabine 14 Cyclophosphamide 14 Doxorubicin 13 pembrolizumab 12 Imatinib Mesylate 9 Docetaxel 9 Radiation 8 Nivolumab 8 Ifosfamide 8 Bevacizumab 8 Sirolimus 7 Filgrastim 7 Everolimus 7 Carboplatin 7 Vincristine 6 pazopanib 5 Specimen Handling 5 Peripheral Blood Stem Cell Transplantation 5 PM 01183 5 Etoposide 5 Biopsy 5 temsirolimus 4 lenvatinib 4 avelumab 4 atezolizumab 4 X-Rays 4 Vorinostat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Duke University

Phase 1/2 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡